Overview
In the second episode Kathryn Thomas digs deeper into what is driving the need for GLP-1 medications and looks to the wider societal impact of their widespread use.
In the second episode Kathryn Thomas digs deeper into what is driving the need for GLP-1 medications and looks to the wider societal impact of their widespread use.
Comments
Be the first to comment.
Leave a comment
Your email won't be published. Comments are reviewed before they appear.